Type I interferons in infectious disease

Finlay McNab; Katrin Mayer-Barber; Alan Sher; Andreas Wack; Anne O'Garra

doi:10.1038/nri3787

journal article Jan 23, 2015

Type I interferons in infectious disease

Finlay McNab Katrin Mayer-Barber Alan Sher

Andreas Wack

Anne O'Garra

Nature Reviews Immunology Vol. 15 No. 2 pp. 87-103 · Springer Science and Business Media LLC

View at Publisher Save 10.1038/nri3787

Topics

No keywords indexed for this article. Browse by subject →

References

237

[1]

Pestka, S., Krause, C. D. & Walter, M. R. Interferons, interferon-like cytokines, and their receptors. Immunol. Rev. 202, 8–32 (2004). 10.1111/j.0105-2896.2004.00204.x

[2]

Schoenborn, J. R. & Wilson, C. B. Regulation of interferon-γ during innate and adaptive immune responses. Adv. Immunol. 96, 41–101 (2007). 10.1016/s0065-2776(07)96002-2

[3]

O'Brien, T. R., Prokunina-Olsson, L. & Donnelly, R. P. IFN-λ4: the paradoxical new member of the interferon λ family. J. Interferon Cytokine Res. 34, 829–838 (2014). 10.1089/jir.2013.0136

[4]

Prokunina-Olsson, L. et al. A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus. Nature Genet. 45, 164–171 (2013). 10.1038/ng.2521

[5]

IL-28A, IL-28B, and IL-29: Promising cytokines with type I interferon-like properties

Katrin Witte, Ellen Witte, Robert Sabat et al.

Cytokine & Growth Factor Reviews 2010 10.1016/j.cytogfr.2010.04.002

[6]

Durbin, R. K., Kotenko, S. V. & Durbin, J. E. Interferon induction and function at the mucosal surface. Immunol. Rev. 255, 25–39 (2013). 10.1111/imr.12101

[7]

Yan, N. & Chen, Z. J. Intrinsic antiviral immunity. Nature Immunol. 13, 214–222 (2012). 10.1038/ni.2229

[8]

Goubau, D., Deddouche, S. & Reis e Sousa, C. Cytosolic sensing of viruses. Immunity 38, 855–869 (2013). 10.1016/j.immuni.2013.05.007

[9]

Paludan, S. R. & Bowie, A. G. Immune sensing of DNA. Immunity 38, 870–880 (2013). 10.1016/j.immuni.2013.05.004

[10]

Leber, J. H. et al. Distinct TLR- and NLR-mediated transcriptional responses to an intracellular pathogen. PLoS Pathog. 4, e6 (2008). 10.1371/journal.ppat.0040006

[11]

Pandey, A. K. et al. NOD2, RIP2 and IRF5 play a critical role in the type I interferon response to Mycobacterium tuberculosis. PLoS Pathog. 5, e1000500 (2009). 10.1371/journal.ppat.1000500

[12]

Watanabe, T. et al. NOD1 contributes to mouse host defense against Helicobacter pylori via induction of type I IFN and activation of the ISGF3 signaling pathway. J. Clin. Invest. 120, 1645–1662 (2010). 10.1172/jci39481

[13]

Moreira, L. O. & Zamboni, D. S. NOD1 and NOD2 signaling in infection and inflammation. Front. Immunol. 3, 328 (2012). 10.3389/fimmu.2012.00328

[14]

Moynagh, P. N. TLR signalling and activation of IRFs: revisiting old friends from the NF-κB pathway. Trends Immunol. 26, 469–476 (2005). 10.1016/j.it.2005.06.009

[15]

Type I Inteferon Gene Induction by the Interferon Regulatory Factor Family of Transcription Factors

Kenya Honda, Akinori Takaoka, Tadatsugu Taniguchi

Immunity 2006 10.1016/j.immuni.2006.08.009

[16]

The IRF Family Transcription Factors in Immunity and Oncogenesis

Tomohiko Tamura, Hideyuki Yanai, David Savitsky et al.

Annual Review of Immunology 2008 10.1146/annurev.immunol.26.021607.090400

[17]

Regulation of type I interferon responses

Lionel B. Ivashkiv, Laura T. Donlin

Nature Reviews Immunology 2014 10.1038/nri3581

[18]

Rauch, I., Muller, M. & Decker, T. The regulation of inflammation by interferons and their STATs. JAKSTAT 2, e23820 (2013).

[19]

Viral tricks to grid-lock the type I interferon system

Gijs A Versteeg, Adolfo García-Sastre

Current Opinion in Microbiology 2010 10.1016/j.mib.2010.05.009

[20]

McNab, F. W., Rajsbaum, R., Stoye, J. P. & O'Garra, A. Tripartite-motif proteins and innate immune regulation. Curr. Opin. Immunol. 23, 46–56 (2011). 10.1016/j.coi.2010.10.021

[21]

Diamond, M. S. & Schoggins, J. W. Host restriction factor screening: let the virus do the work. Cell Host Microbe 14, 229–231 (2013). 10.1016/j.chom.2013.08.014

[22]

Muller, U. et al. Functional role of type I and type II interferons in antiviral defense. Science 264, 1918–1921 (1994). 10.1126/science.8009221

[23]

Haller, O., Arnheiter, H., Gresser, I. & Lindenmann, J. Virus-specific interferon action. Protection of newborn Mx carriers against lethal infection with influenza virus. J. Exp. Med. 154, 199–203 (1981). 10.1084/jem.154.1.199

[24]

Durbin, J. E. et al. Type I IFN modulates innate and specific antiviral immunity. J. Immunol. 164, 4220–4228 (2000). 10.4049/jimmunol.164.8.4220

[25]

Garcia-Sastre, A. et al. The role of interferon in influenza virus tissue tropism. J. Virol. 72, 8550–8558 (1998). 10.1128/jvi.72.11.8550-8558.1998

[26]

Koerner, I., Kochs, G., Kalinke, U., Weiss, S. & Staeheli, P. Protective role of β interferon in host defense against influenza A virus. J. Virol. 81, 2025–2030 (2007). 10.1128/jvi.01718-06

[27]

Price, G. E., Gaszewska-Mastarlarz, A. & Moskophidis, D. The role of α/β and γ interferons in development of immunity to influenza A virus in mice. J. Virol. 74, 3996–4003 (2000). 10.1128/jvi.74.9.3996-4003.2000

[28]

Mordstein, M. et al. λ Interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections. J. Virol. 84, 5670–5677 (2010). 10.1128/jvi.00272-10

[29]

Mordstein, M. et al. Interferon-λ contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses. PLoS Pathog. 4, e1000151 (2008). This study demonstrates the redundant roles of type I and type III IFNs in the anti-influenza virus response, clarifying the confusion arising from earlier literature that reported that type I IFNs cannot account for the requirement for STAT1 signalling in protection against influenza virus infection. 10.1371/journal.ppat.1000151

[30]

Crotta, S. et al. Type I and type III interferons drive redundant amplification loops to induce a transcriptional signature in influenza-infected airway epithelia. PLoS Pathog. 9, e1003773 (2013). This study demonstrates the redundant roles of type I and type III IFN signalling in epithelial cells in the anti-influenza virus response, clarifying the confusion arising from earlier literature over protection against influenza virus infection. 10.1371/journal.ppat.1003773

[31]

Inborn Errors of Human JAKs and STATs

Jean-Laurent Casanova, Steven M. Holland, Luigi D. Notarangelo

Immunity 2012 10.1016/j.immuni.2012.03.016

[32]

Zhang, S. Y. et al. Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-α/β, IFN-γ, and IFN-λ in host defense. Immunol. Rev. 226, 29–40 (2008). 10.1111/j.1600-065x.2008.00698.x

[33]

Suppiah, V. et al. IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy. Nature Genet. 41, 1100–1104 (2009). 10.1038/ng.447

[34]

Tanaka, Y. et al. Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C. Nature Genet. 41, 1105–1109 (2009). 10.1038/ng.449

[35]

Ge, D. et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461, 399–401 (2009). 10.1038/nature08309

[36]

Thomas, D. L. et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 461, 798–801 (2009). 10.1038/nature08463

[37]

Sandler, N. G. et al. Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression. Nature 511, 601–605 (2014). 10.1038/nature13554

[38]

Everitt, A. R. et al. IFITM3 restricts the morbidity and mortality associated with influenza. Nature 484, 519–523 (2012). This study provided the first evidence of host genetics ( IFITM3 ) contributing to susceptibility to influenza virus infection in humans. 10.1038/nature10921

[39]

Zhang, Y. H. et al. Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals. Nature Commun. 4, 1418 (2013). This is a follow-up study to reference 38, showing that IFITM3 variants that contribute to the severity of influenza virus infection are predominant in the Chinese population. 10.1038/ncomms2433

[40]

Staeheli, P., Grob, R., Meier, E., Sutcliffe, J. G. & Haller, O. Influenza virus-susceptible mice carry Mx genes with a large deletion or a nonsense mutation. Mol. Cell. Biol. 8, 4518–4523 (1988).

[41]

Horisberger, M. A., Staeheli, P. & Haller, O. Interferon induces a unique protein in mouse cells bearing a gene for resistance to influenza virus. Proc. Natl Acad. Sci. USA 80, 1910–1914 (1983). 10.1073/pnas.80.7.1910

[42]

Horby, P., Nguyen, N. Y., Dunstan, S. J. & Baillie, J. K. The role of host genetics in susceptibility to influenza: a systematic review. PLoS ONE 7, e33180 (2012). 10.1371/journal.pone.0033180

[43]

Dauer, M. et al. Interferon-α disables dendritic cell precursors: dendritic cells derived from interferon-α-treated monocytes are defective in maturation and T-cell stimulation. Immunology 110, 38–47 (2003). 10.1046/j.1365-2567.2003.01702.x

[44]

Lapenta, C. et al. Potent immune response against HIV-1 and protection from virus challenge in hu-PBL-SCID mice immunized with inactivated virus-pulsed dendritic cells generated in the presence of IFN-α. J. Exp. Med. 198, 361–367 (2003). 10.1084/jem.20021924

[45]

Santini, S. M. et al. Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice. J. Exp. Med. 191, 1777–1788 (2000). 10.1084/jem.191.10.1777

[46]

Santodonato, L. et al. Monocyte-derived dendritic cells generated after a short-term culture with IFN-α and granulocyte-macrophage colony-stimulating factor stimulate a potent Epstein-Barr virus-specific CD8+ T cell response. J. Immunol. 170, 5195–5202 (2003). 10.4049/jimmunol.170.10.5195

[47]

Hahm, B., Trifilo, M. J., Zuniga, E. I. & Oldstone, M. B. Viruses evade the immune system through type I interferon-mediated STAT2-dependent, but STAT1-independent, signaling. Immunity 22, 247–257 (2005). 10.1016/j.immuni.2005.01.005

[48]

Ito, T. et al. Differential regulation of human blood dendritic cell subsets by IFNs. J. Immunol. 166, 2961–2969 (2001). 10.4049/jimmunol.166.5.2961

[49]

Montoya, M. et al. Type I interferons produced by dendritic cells promote their phenotypic and functional activation. Blood 99, 3263–3271 (2002). 10.1182/blood.v99.9.3263

[50]

Le Bon, A. et al. Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon. Nature Immunol. 4, 1009–1015 (2003). 10.1038/ni978

Showing 50 of 237 references

Cited By

2,482

EBV encoded tegument protein BKRF4 suppresses RLR signaling pathway-mediated interferon production through inhibiting the activation of IRF3 and IRF7

Meili Li, Xinghong Gao · 2026

International Journal of Medical Mi...

Persistent myeloid cell reprogramming despite miltefosine treatment in leishmania-infected macaques

Morgane Picard, Steven Boutrais · 2025

iScience

Toll-like receptor 3: a double-edged sword

Marvin L Hsieh, Daisuke Nishizaki · 2025

Biomarker Research

Nanoparticle approaches for manipulating cytokine delivery and neutralization

Rui Wang, Luke J. Kubiatowicz · 2025

Frontiers in Immunology

Tibial cortex transverse transport surgery improves wound healing in patients with severe type 2 DFUs by activating a systemic immune response: a cross-sectional study

Lin Yu, Yuan Yin · 2024

International Journal of Surgery

A Comprehensive Review on Porcine Reproductive and Respiratory Syndrome Virus with Emphasis on Immunity

Jorian Fiers, Ann Brigitte Cay · 2024

Vaccines

Mapping the gene space at single-cell resolution with gene signal pattern analysis

Aarthi Venkat, Sam Leone · 2024

Nature Computational Science

Metabolic adaptations determine whether natural killer cells fail or thrive within the tumor microenvironment

Adnan Moinuddin, Sophie M. Poznanski · 2024

Immunological Reviews

Self-recruited neutrophils trigger over-activated innate immune response and phenotypic change of cardiomyocytes in fulminant viral myocarditis

Huihui Li, Mingzhi Zhang · 2023

Cell Discovery

STING inhibits the reactivation of dormant metastasis in lung adenocarcinoma

Jing Hu, Francisco J. Sánchez-Rivera · 2023

Nature

Macrophage: Key player in the pathogenesis of autoimmune diseases

Shuang Yang, Ming Zhao · 2023

Frontiers in Immunology

HIV/Mtb Co-Infection: From the Amplification of Disease Pathogenesis to an “Emerging Syndemic”

José Miguel Azevedo-Pereira, David Pires · 2023

Microorganisms

Molecular Evolution of Interferon-Epsilon (IFNε) Pseudogene Modulates Innate and Specific Antiviral Immunity in Manis javanica

Hafiz Ishfaq Ahmad, Laraib Jameel · 2023

Journal of Zoological Systematics a...

Histopathological and molecular links of COVID-19 with novel clinical manifestations for the management of coronavirus-like complications

Ankita Sood, Onkar Bedi · 2022

Inflammopharmacology

Early plasma interferon‐β levels as a predictive marker of COVID‐19 severe clinical events in adult patients

Fatma Berri, Yohan N'Guyen · 2022

Journal of Medical Virology

Interferons in Pain and Infections: Emerging Roles in Neuro-Immune and Neuro-Glial Interactions

Ping-Heng Tan, Jasmine Ji · 2021

Frontiers in Immunology

How dendritic cells sense and respond to viral infections

Laura Marongiu, Mihai Valache · 2021

Clinical Science

Genome instability independent of type I interferon signaling drives neuropathology caused by impaired ribonucleotide excision repair

Aditi, Susanna M. Downing · 2021

Neuron

Innate immunology in COVID-19—a living review. Part II: dysregulated inflammation drives immunopathology

Patrícia R S Rodrigues, Aljawharah Alrubayyi · 2020

Oxford Open Immunology

RIG-I-like receptors: their regulation and roles in RNA sensing

Jan Rehwinkel, Michaela U. Gack · 2020

Nature Reviews Immunology

Metrics

2,482

Citations

237

References

Details

Published: Jan 23, 2015
Vol/Issue: 15(2)
Pages: 87-103
License: View

Authors

Departments of Molecular Biology, DNAX Research Institute of Molecular and Cellular Biology Inc., Palo Alto, California 94304;; Departments of Pharmacology, DNAX Research Institute of Molecular and Cellular Biology Inc., Palo Alto, California 94304;; Departments of Immunology, DNAX Research Institute of Molecular and Cellular Biology Inc., Palo Alto, California 94304;,

Cite This Article

Finlay McNab, Katrin Mayer-Barber, Alan Sher, et al. (2015). Type I interferons in infectious disease. Nature Reviews Immunology, 15(2), 87-103. https://doi.org/10.1038/nri3787

Type I interferons in infectious disease

You May Also Like